Erythromycin And Benzoyl Peroxide Kit
Pricing Report NDC 68682-901-46

Latest NADAC: $0.93746 per GM · Effective Sep 17, 2025

Current Package Pricing Information

The latest wholesale acquisition cost for Erythromycin And Benzoyl Peroxide (NDC 68682-901-46) is $0.93746 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 17, 2025.

As a a human prescription drug provided by Oceanside Pharmaceuticals, this medication is distributed in a 1 KIT in 1 CARTON * 40 g in 1 JAR (68682-922-46) * 1.6 g in 1 VIAL, PLASTIC (68682-925-16) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.93746
Per GM

Effective Date
Sep 17, 2025
Data Status
As of Oct 01, 2025
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 KIT in 1 CARTON * 40 g in 1 JAR (68682-922-46) * 1.6 g in 1 VIAL, PLASTIC (68682-925-16)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jun 2015, the NADAC wholesale price for (NDC ) has moved within a range of $0.70999 to $6.55371 per GM. Over this 10 years and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.7100 - $6.5537
Market Volatility
823.07% Variance
Latest Trend
0.71%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 17, 2025 $0.93746 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 20, 2025 $0.93085 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 23, 2025 $0.96584 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 18, 2025 $0.98602 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 21, 2025 $1.00928 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 23, 2025 $1.01132 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 19, 2025 $0.99961 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 19, 2025 $0.94255 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 22, 2025 $0.86065 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 18, 2024 $0.85009 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 20, 2024 $0.78364 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 23, 2024 $0.94083 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026